Original Research: Exploring the Use of Passive vs. Active Insulin Safety Pen Needle Devices in a Pediatric

Brenna Frankish1, Kristina Amplo, Rachael Townsend

  • 1Brenna Frankish is the clinical learning programs coordinator at Children's Healthcare of Atlanta, where Kristina Amplo is the campus education coordinator and Christina Calamaro is the director of nursing research and evidence-based practice for nursing and allied health. Rachael Townsend is the pediatric program manager at Wellstar Health System in Marietta, GA. Tonya Miller-Roberts is a clinical psychologist at the Atlanta VA Medical Center in Decatur, GA. Akane Fujimoto Wakabayashi is a graduate research assistant at the Georgia Institute of Technology in Atlanta. This study was supported through funding from Owen Mumford, Ltd, which also supplied the active safety pen needle devices used. Contact author: Brenna Frankish, brenna.frankish@gmail.com . The authors have disclosed no potential conflicts of interest, financial or otherwise.

PubMed

Insights

Nurses preferred active safety pen needles (SPNs) over passive SPNs for pediatric insulin delivery due to improved ease of use and confidence in accurate dosing. This suggests active SPNs are a valuable advancement for pediatric diabetes care.

Area of Science:

  • Pediatric Endocrinology
  • Medical Device Technology
  • Nursing Practice

Background:

  • Insulin pens are crucial for pediatric diabetes management, particularly for those not using insulin pumps.
  • Safety pen needle (SPN) devices reduce needlestick injuries and pathogen exposure.
  • Traditional passive SPNs present challenges in confirming accurate and complete insulin dose administration.

Purpose of the Study:

  • To evaluate nurses' perceptions of an active SPN device compared to a passive SPN device for pediatric subcutaneous insulin injections.
  • To assess the feasibility of implementing the Unifine SafeControl active SPN device in a pediatric setting.

Main Methods:

  • A feasibility study involving 49 registered nurses (RNs) on a pediatric inpatient unit.
  • RNs completed pre- and post-device change surveys comparing passive and active SPN devices.
  • Daily evaluations assessed the ease of teaching active SPN device use to pediatric patients and caregivers.
  • Informed consent was obtained from 132 pediatric patients with diabetes.

Main Results:

  • High overall satisfaction reported for the active SPN device (87.8%) compared to the passive SPN device (52.7%).
  • Nearly all RNs found the active SPN device easy to use (98.6%) and felt confident in delivering the full dose (93.9%).
  • Teaching patients (98.2%) and caregivers (96.4%) how to use the active SPN device was reported as easy or very easy.

Conclusions:

  • Nurses' positive perceptions of the active SPN device highlight its potential for improved patient safety and care.
  • The active SPN device demonstrated superior ease of use, dose administration confidence, and teaching efficiency compared to the passive device.
  • The findings support wider adoption of active SPN devices in hospital settings and suggest further research.
Abstract